MENG NIU2月5日，国家卫生健康委员会（下称“卫健委”）正式发布公告，蒙牛集团自主研发的3’-唾液酸乳糖钠盐（3’-SL）成功获批。这是3’-SL在国内的首次批准，标志着我国在母乳低聚糖（HMO）领域的产业发展进入全新阶段。蒙牛也因此成为中国首家且唯一同时通过2’-岩藻糖基乳糖(2’-FL)、乳糖-N-新四糖(LNnT)及3’-唾液酸乳糖钠盐（3’-SL）卫健委审批的本土企业。此次获批是对...
Source LinkMENG NIU2月5日，国家卫生健康委员会（下称“卫健委”）正式发布公告，蒙牛集团自主研发的3’-唾液酸乳糖钠盐（3’-SL）成功获批。这是3’-SL在国内的首次批准，标志着我国在母乳低聚糖（HMO）领域的产业发展进入全新阶段。蒙牛也因此成为中国首家且唯一同时通过2’-岩藻糖基乳糖(2’-FL)、乳糖-N-新四糖(LNnT)及3’-唾液酸乳糖钠盐（3’-SL）卫健委审批的本土企业。此次获批是对...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.